Haitao Cui

Haitao Cui

Auto-generated profile, based on publicly available information

Haitao Cui

Chongqing University, No.83 Shazheng Street, Chongqing University (Campus B), Chongqing, Chongqing, 400044, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
HCHaitao Cui
Haitao Cui
CLChengyu Liu
Chengyu Liu
TETimothy Esworthy
Timothy Esworthy
YHYimin Huang
Yimin Huang
ZYZu-Xi Yu
Zu-Xi Yu
LZLijie Grace Zhang
Lijie Grace Zhang
A 4D cardiac patch with physiological adaptability may improve iPSC cell therapy for the treatment of myocardial infarction.

22 December 2022 in Organic Letters
Verified
Journal Article
Closed access
HCHaitao Cui
Haitao Cui
CBCaijin Ban
Caijin Ban
FZFengting Zhu
Fengting Zhu
JYJingmei Yuan
Jingmei Yuan
JDJuan Du
Juan Du
QZQiang Zhu
Qiang Zhu

24 April 2025 in Advanced Functional Materials
Verified
Journal Article
Closed access
YLYan Li
Yan Li
HCHaijun Cui
Haijun Cui
HCHaitao Cui
Haitao Cui

15 April 2025 in Nanoscale
Verified
Journal Article
Closed access
PDF file
PWPengyan Wu
Pengyan Wu
ZZZhengjie Zhang
Zhengjie Zhang
YHYan Hu
Yan Hu
YLYan Li
Yan Li
TZTong Zhu
Tong Zhu
HCHaijun Cui
Haijun Cui
We report a biomimetic hydrogel reinforced with cellulose nanocrystals that mimics the anisotropic mechanical properties of bamboo, enhancing both strength and functionality.

12 March 2026 in Biofabrication
Verified
Journal Article
Closed access
XTXingyu Tang
Xingyu Tang
HCHaijun Cui
Haijun Cui
HCHaitao Cui
Haitao Cui
The incidence of Parkinson’s disease (PD) has been steadily increasing globally, while traditional two-dimensional cell cultures and animal models face significant challenges in effectively elucidating its complex pathological mechanisms and screening potential drugs. Advanced in vitro models that incorporate patient-specific characteristics and three-dimensional (3D) microenvironments have emerged as powerful alternatives. This review first outlines current perspectives on PD etiology and pathogenesis, highlighting their implications for 3D modeling systems. A systematic comparison evaluates organoid, microfluidic, and 3D bioprinting platforms by leveraging their recent applications in PD mechanistic studies and therapeutic screening. The utilization of these cutting-edge technologies in PD model development not only deepens mechanistic insights but also streamlines therapeutic innovation, paving the way for effective treatments against this debilitating neurodegenerative disorder.